A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer
Clinical trial NCT06340581 · WITHDRAWN
Trial details
- NCT number
- NCT06340581
- Sponsor
- AstraZeneca
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-17
- Primary completion
- 2025-02-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.